Oncolytics Biotech (ONCY)
(Delayed Data from NSDQ)
$1.18 USD
-0.01 (-0.84%)
Updated May 8, 2024 04:00 PM ET
After-Market: $1.18 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: AMC |
3/2024 | $-0.09 | 0.00% |
Earnings Summary
For their last quarter, Oncolytics Biotech (ONCY) reported earnings of -$0.04 per share, beating the Zacks Consensus Estimate of $-0.11 per share. This reflects a positive earnings surprise of 63.64%. Look out for ONCY's next earnings release on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting a year-over-year decrease of 28.57%.
Earnings History
Price & Consensus
Zacks News for ONCY
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
ONCY: What are Zacks experts saying now?
Zacks Private Portfolio Services